Latest Trials


EudraCT Number: 2004-005007-14 Sponsor Protocol Number: 20040122 Start Date: 2005-05-20
Sponsor Name: Amgen Inc
Full Title: A Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Palifermin (Recombinant Human Keratinocyte Growth Factor) for Reduction of Oral Mucositis in Subjects Wit...
Medical condition: Oral Mucositis
Disease: Version SOC Term Classification Code Term Level
16.1 100000004856 10028130 Mucositis oral LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) CZ (Completed) BE (Completed)
Trial results: View results
3
Subscribe